research use only

DL-Lactic acid Glycolysis Production

Cat.No.E4473

Lactate (Lactic acid) is the product of glycolysis, produced due to lack of oxygen in contracting skeletal muscle in vivo, and can be utilised under fully aerobic conditions. It plays a key role as a metabolic intermediate and can be used as hemodynamic marker and resuscitation endpoint in several cohorts of critically ill patients.
Jump to

Quality Control

Batch: E447301 DMSO]18 mg/mL]false]Water]18 mg/mL]false]Ethanol]18 mg/mL]false Purity: 91.2%
91.2

Solubility

In vitro
Batch:

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 90.08 Formula

C3H6O3

Storage (From the date of receipt) 2 years  -20°C  liquid
CAS No. 50-21-5 Download SDF

Read more about storage stability stock solution CAS number

Mechanism of Action

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-01-16)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06701760 NOT_YET_RECRUITING
Traumatic Brain Injury
University of California, Los Angeles
2028-01-10 PHASE2
NCT06950060 ACTIVE_NOT_RECRUITING
Stroke, Chronic; Aging; Cognitive Decline; Motor Dysfunction; Neuroplasticity
University of Alabama at Birmingham
2026-07-15
NCT07774520 RECRUITING
Non-small Cell Lung Cancer(NSCLC); EGFR Mutant
Samsung Medical Center
2026-05-26 PHASE2
NCT06558422 NOT_YET_RECRUITING
Insulin Resistance; Hyperinsulinemia; Metabolic Dysfunction Associated Steatotic Liver Disease; Non-Alcoholic Fatty Liver Disease; Prediabetic State; Obesity
Columbia University
2027-01-01 PHASE1
NCT07733206 NOT_YET_RECRUITING
Sepsis
University Hospital Center of Martinique
2026-09-15
NCT07160426 NOT_YET_RECRUITING
Sepsis
Beth Israel Deaconess Medical Center
2026-07-01 PHASE2

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.